Fundz

Neoplas Med GmbH secured an additional $18M funding from Niterra Ventures Company to enhance its innovative wound care technology and expand market reach.

PRIVATENov 25, 2024

Amount Raised

$18 Million

Round Type

Funding Round

GreifswaldBiotechnologyHealth CareMedicalMedical Device

Investors

Niterra Ventures Company

Description

Neoplas Med GmbH has increased its collaboration with Niterra Ventures Company through an $18M capital infusion aimed at expanding the innovative wound care technology market. This follows a prior investment bringing the total to $25M, enabling advancements in their unique plasma jet therapy.

Quick answer

Neoplas Med GmbH raised $18 Million in a Funding Round round, dated November 25, 2024. Investors: Niterra Ventures Company. Neoplas Med GmbH is based in Greifswald, Mecklenburg-Vorpommern, Germany.

How much did Neoplas Med GmbH raise?
Neoplas Med GmbH raised $18 Million in a Funding Round round on November 25, 2024.
Who invested in Neoplas Med GmbH?
Niterra Ventures Company is named as investors in this round.
What does Neoplas Med GmbH do?
neoplas med GmbH was founded in 2009 as a spin-off of the Leibniz Institute for Plasma Science and Technology e.
Where is Neoplas Med GmbH based and how big is it?
Neoplas Med GmbH is based in Greifswald, Mecklenburg-Vorpommern, Germany. Fundz records about 20 employees.
Who are the decision-makers at Neoplas Med GmbH?
Fundz holds 2 contacts at Neoplas Med GmbH. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Neoplas Med GmbH that raised within 45 days of this round, from Fundz verified event records.

  • Field Medical raised $27M on January 8, 2025.
  • SpineGuard® raised $104K (Pre-Seed) on January 7, 2025.
  • Outset Medical raised $3.9M (Seed) on January 3, 2025.
  • QTREX Quantum Ltd raised $8.3M on December 27, 2024.
  • Lazurite raised $1.7M (Seed) on December 26, 2024.
  • SpinaFX raised $5.3M (Series B) on December 19, 2024.

Who to call at Neoplas Med GmbH, and when

A new round usually means Neoplas Med GmbH is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neoplas Med GmbH raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neoplas Med GmbH, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neoplas Med GmbH. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neoplas Med GmbH

Location

Greifswald, Mecklenburg-Vorpommern, Germany

About

neoplas med GmbH was founded in 2009 as a spin-off of the Leibniz Institute for Plasma Science and Technology e. V. (INP) in Greifswald, Germany. Based on the INP research into plasma medicine, the emerging company develops innovative products for medical applications. The first product developed on this basis is the CE-marked kINPen® MED atmospheric pressure plasmajet, the first internationally approved and marketed plasma jet for the treatment of chronic wounds and pathogen-induced skin disorders. It is the result of a long-lasting cooperation with the INP institute, the university hospital of Greifswald, Germany, the Charité hospital of Berlin, Germany, and various industrial partners.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neoplas Med GmbH raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Neoplas Med GmbH's next move

See what Strategic adds

Neoplas Med GmbH raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.